Related Experiment Videos
The antitumoral compound Kahalalide F acts on cell lysosomes
M García-Rocha1, P Bonay, J Avila
1Centro de Biología Molecular, Universidad Autónoma de Madrid, Spain.
Cancer Letters
|January 19, 1996
Abstract:
The target for the antitumoral peptidic drug, Kahalalide F, has been studied in cultured cells. In the presence of the compound, the cells became impressively swollen, showing the formation of large vacuoles. The formation of these vacuoles appears to be the consequence of changes in lysosomal membranes. Thus, lysosomes are a target for Kahalalide F action.